IDAC Seminar to commemorate the retirement of Professor Ishioka
Date	Monday, 11 March 2024, 16:00〜
Room	International Conference Room, Center for Smart-Aging Research, 1F, (IDAC)
Title	Perspective of personalized cancer medicine.
Speaker	Professor Chikashi Ishioka
Affiliation	Department of Clinical Oncology, Tohoku University School of Medicine
Organizer	Masanobu Takahashi（Dept. of Clinical Oncology・ext 8543） Syonosuke Wakayama (Dept. of Clinical Oncology・ext 8543)
Abstract	Cancer has been the leading cause of death in Japan and other OECD countries for a long time, but the age-adjusted morbidity and mortality rates of cancer patients are gradually improving through a wide range of cancer acts, including improvements in prevention, screening and treatment methods. However, treatment outcomes for advanced cancer have not yet reached a level that satisfies patients and their families. Cancer drug therapy, which is the mainstay of treatment for unresectable advanced and recurrent cancers, has improved by developing new cancer molecular targeting drugs and improving technologies on comprehensive molecular analyses such as cancer genome analysis. Cancer treatment is rapidly moving toward an era of individualization, with a shift from organ-specific cancer treatment to organ-agnostic treatment based on the mechanisms of cancer development and progression. In this lecture, I will look back on my 40 years of research as a medical oncologist, summarize the trends, achievements, and challenges in the developing field of personalized cancer medicine, and look at the future direction of this field.